Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a small molecule that can inhibit a cancer ...
Confused about protein recommendations? We asked protein experts on what exactly is the answer. Plus, everything else you ...
In addition to CG001419, Cullgen continues the advancement of CG009301, a GSPT1 degrader being studied in a Phase 1 trial for the treatment of blood cancers, as well as progressing its pipeline of pre ...
While the 21st century has been bumpy, it has also ushered in monumental scientific and technological breakthroughs that have ...
This research led to Balu-Iyer founding the Buffalo-based company Immune Modulatory Therapies LLC in 2019. His UB co-founders ...
Perfect Day says Gujarat facility on track for 2026 start, 2027 ramp-up for recombinant whey protein
COO Marshall Bredwell says Perfect Day is "confident in instant profitability at plant launch" for its precision fermentation plant in India.
In connection with the proposed offering, Vera Therapeutics expects to grant the underwriters a 30-day option to purchase up ...
Two scientists at the Johns Hopkins School of Medicine have been selected for membership in the National Academy of Inventors ...
Reportedly distributed across nearly 75% of the country, the product in question "fails to declare" one very important ingredient.
Trevor Noah joined a 5th grade computer science class in Bellevue for Code.org’s Hour of AI, a Microsoft-supported initiative ...
Accelerating Demand Driving Strong Revenue Growth Vancouver, British Columbia–(Newsfile Corp. – December 15, 2025) – Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (“Burcon” or the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results